We’re pleased to welcome Dr. Varun Gupta as a core facilitator for the IRTG project. Dr. Gupta will support a new research initiative exploring the role of circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) patients undergoing surgical resection.
The project investigates how anatomical lung resections and neoadjuvant therapies affect the number and characteristics of CTCs and ctDNA. Using advanced microfluidic isolation and sequencing technologies, the study aims to uncover biomarkers that can help predict treatment response, recurrence, and overall prognosis. This integrative approach is expected to improve risk stratification and guide personalized therapeutic strategies for lung cancer patients.
We’re excited to have Dr. Gupta on board as we push the frontiers of precision oncology in NSCLC.